COLLECTION AND HANDLING Clause Samples
The COLLECTION AND HANDLING clause defines the procedures and responsibilities for gathering, managing, and processing certain items, materials, or information relevant to the agreement. Typically, it outlines who is responsible for collecting the specified items, how they should be handled or stored, and any standards or protocols that must be followed during these processes. For example, in a contract involving goods, this clause might specify how products are to be packaged, labeled, and transferred between parties. Its core practical function is to ensure that all parties understand their obligations regarding the proper collection and management of relevant items, thereby reducing the risk of loss, damage, or disputes over handling procedures.
COLLECTION AND HANDLING. Specimen: Serum or plasma from samples collected in EDTA may be used. Do not use plasma collected in heparin. Fresh serum is the specimen of choice.
COLLECTION AND HANDLING. Specimen: The specimen may be serum, cerebrospinal fluid (CSF) or urine. Serum specimens should be free of hemolysis or lipemia. A fibrinogen band, which may obscure the beta-gamma zone, will appear in plasma samples. Storage: Fresh serum is the specimen of choice. If storage is necessary, samples may be stored covered at 2 to 8°C for 48 hours.
COLLECTION AND HANDLING. Specimen: Freshly collected serum and CSF are the specimens of choice. Both serum and CSF should be collected at the same time using conventional collection methods for clinical laboratory testing. Handling: CSF samples should be applied neat. Serum samples should be diluted 1:300 in 0.85% saline. Storage and Stability: Samples can be stored refrigerated at 2 to 8°C for up to 3 days or 2 weeks at -20°C.
COLLECTION AND HANDLING. Use a 2.0 cc syringe to obtain the blood specimen as follows: Extracorporeal line: Using a two-syringe technique, flush the extracorporeal blood access line by withdrawing 2.0 cc of blood into a syringe and discarding it. Then use a second syringe to obtain a 0.5 cc sample for testing. In-dwelling line: Discontinue fluids drip, if necessary. Using a two-syringe technique, withdraw 2.0 cc of blood into a syringe and discard it. Then use a second syringe to obtain a 0.5 cc sample for testing. Venipuncture: Using a two-syringe technique, withdraw 2.0 cc of blood into a syringe and discard it. Then use a second syringe to obtain a 0.5 cc sample for testing.
COLLECTION AND HANDLING. Specimen: Serum is the specimen of choice. Plasma collected in heparin may be used. Anticoagulants containing oxalate, citrate or EDTA cannot be used because these substances inhibit the alkaline phosphatase activity.13 Patient Preparation: The patient should be fasting. Patients who have B or O blood group and are secretors may have an elevated ALP about two hours after a fatty meal.6, 12, 13, 18, 19
COLLECTION AND HANDLING. Specimen: Plasma from whole blood collected in sodium citrate as an anticoagulant. Specimen Preparation: Collect the blood specimen in either 3.2% (0.109 M) or 3.8% (0.129 M) sodium citrate. Add nine parts whole blood to one part sodium citrate solution. Centrifuge the blood sample immediately after collection at 1000 x G for 10 minutes. Store the plasma at 2 to 8°C until testing is performed. Plasma stored at 2 to 8°C must be tested within four hours after sample collection. Plasma is stable at -20°C for one month. Plastic tubes must be used for storage and testing.
COLLECTION AND HANDLING. Specimen: Plasma obtained from whole blood collected with 3.2% sodium citrate as an anticoagulant is the specimen of choice. Specimen Collection: Blood may be collected with evacuated test tubes, a 2-syringe technique, or with a butterfly and syringe technique. Accurate coagulation studies depend on the correct whole blood to anticoagulant ratio. For blood specimens with hematocrits (HCT) of <55% (normal), 9 parts of freshly collected whole blood should be immediately added to one part anticoagulant.8 For blood specimens with hematocrits outside the normal range, adjust the amount of whole blood added to the anticoagulant according to the following formula.2 Parts whole blood to 0.6 one part anticoagulant (1 - .HCT) Particular care should be taken when using evacuated test tubes. These tubes are designed to draw 9 parts blood to 1 part anticoagulant. If the hematocrit is determined abnormal, blood should be drawn into a syringe and an appropriate amount mixed with an adjusted volume of citrate anticoagulant. Specimen Preparation: Centrifuge the whole blood specimen at 1600-2000 x G for 10 minutes. Immediately separate the plasma from the red blood cells, and place it in a plastic test tube with cap. Storage and Stability: Prior to testing, the plasma should be stored in the capped plastic tubes at 2 to 8°C. If testing is delayed for more than 2 hours, the plasma may be stored at -20°C or colder for up to one month. Thaw quickly at 37°C prior to testing, but do not allow to stand at 37°C for more than 5 minutes. Lyophilized Platelets - Cat. No. 5356 Platelet Aggregometer (AggRAM Analyzer recommended) Plastic pipette tips Plastic or siliconized test tubes Pipettes to deliver 50 µL or 25 µL Pipettes to deliver 400 µL or 200 µL
COLLECTION AND HANDLING. Specimen: Plasma obtained from whole blood collected with 3.2% sodium citrate as an anticoagulant is the specimen of choice. Hemolyzed samples may cause erroneous aggregation results.
COLLECTION AND HANDLING. Specimen: For serum protein analysis, freshly collected serum is the specimen of choice as plasma samples will contain a large fibrinogen peak between the beta and gamma fractions. Storage and Stability: Samples can be stored at 2 to 8°C for up to 7 days and up to 6 months at -20°C. If samples are to be stored frozen, they should be refrigerated immediately and frozen within 8 hours of collection. Storing samples at 2 to 8°C can result in protein degradation, particularly, but not exclusively of complement fractions. Consequently, after 7 days storage at 2 to 8°C, detection of a distinct beta2 region may no longer be possible. DO NOT store samples at room temperature - the sample will degrade rapidly. Samples which contain cryoglobulins may become viscous or turbid after refrigeration or freezing. It is advisable to warm these samples to room temperature before analysis. PROCEDURE Materials provided: The following materials are provided: Sample Test Size Cat. No. 50 1803C Anti-human IgG antisera 1 vial Anti-human IgA antisera 1 vial Anti-human IgM antisera 1 vial Anti-human kappa antisera 1 vial Anti-human lambda antisera 1 vial Materials provided but not contained in the above kit: Item Cat. No. V8 Velocity Analyzer 1800 V8 Nexus CE Analyzer 1825 V8 Storage Buffer 1831 V8 Maintenance Buffer 1832 V8 Serum Protein SPE Kit 1805 V8 Clinical Waste Drawer Inserts 1820 Materials required but not provided: Item Uncapped primary tubes These instructions are for standard mode versus touch screen. (For correct installation of all consumables, please refer to the Operator Manual)
1. Ensure that the waste container drawer is on-board.
2. Before switching on the V8, ensure that the Storage Buffer, Maintenance Buffer and disposable cups are on-board and in their correct positions.
3. Launch Platinum and begin a new V8 session. In Platinum, select "V8 SYSTEM" from the drop down menu, click "SELECT DEFAULT METHOD" and ensure the relevant Immunodisplacement assay is selected. For reflex testing or individual test ordering, please refer to the Operator Manual.
4. Switch on the V8 as instructed in the Operator Manual.
5. To conduct Immunodisplacement testing, install the relevant Serum Protein Buffer and Diluent if required.
6. Ensure that the Immunodisplacement reagent barcode information is loaded into Platinum by selecting "V8 SYSTEM" from the drop down menu. Click "DEFINE REAGENTS" and ensure the barcode information for each antisera type has been entered and that the lo...
COLLECTION AND HANDLING a. COLLECTION SCHEDULE: The Contractor shall submit a collection schedule not later than ten